Under construction – not a live service
Sign in
Active, not recruitingNo phase

Virtual Reality for Fibromyalgia

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Trial details

Who runs it
Centre Hospitalier Princesse Grace
Trial code
NCT05567861
Record updated
12 March 2025
Original description
Fibromyalgia is a frequent chronic pain syndrome almost often affecting women and associating diffuse chronic musculoskeletal pain (for more than 3 months), fatigue and sleep disturbances. Other varied functional symptoms are associated with it, in particular cognitive disorders and a feeling of unrested awakening.Read full original descriptionShow less

Observational Study on the Effect of Virtual Reality on the Pain Intensity of Patients Suffering From Fibromyalgia

Fibromyalgia is a frequent chronic pain syndrome almost often affecting women and associating diffuse chronic musculoskeletal pain (for more than 3 months), fatigue and sleep disturbances. Other varied functional symptoms are associated with it, in particular cognitive disorders and a feeling of unrested awakening.

Technological advances in virtual reality have led to recognition by the medical community as a way to improve pain and quality of life for patients.

There is a growing body of evidence supporting the use of virtual reality as an adjunct therapy to reduce acute pain in patients during medical procedures in hospital settings. There may also be a role for virtual reality in patients with chronic pain.

Inclusion: Patients able to understand and sign the informed consent form for the study; Adults aged 18 to 65 years; Followed in algology for fibromyalgia pain > 6 months; With mean pain intensity ≥ 4.

Exclusion: Previous use of VR for pain (possible bias); History of epilepsy or hypersensitivity to flashing light to limit the risk of virtual reality-induced seizures; Refusal to participate; Therapeutic modifications for pain management related to fibromyalgia during the first month of participation.

ClinicalTrials.gov NCT05567861